Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Nov 2026 for Regeneron Pharmaceuticals, INC., €3.9M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Joseph LaRosa: trading record in brief
Our data holds just one disclosure by Joseph LaRosa, dated 2 November 2026, reporting a transaction worth €3.9M in Regeneron Pharmaceuticals, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph LaRosa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,466 shares@ US$965.4893common stockSEC144:0001969223-26-001114
1 of 1 declaration